IHS Chemical Week

EnviroTech :: Alternative fuels

Amyris Builds Post-IPO Momentum

2:06 PM MDT | September 26, 2011 | Rebecca Coons

Synthetic biology firm Amyris (Emeryville, CA) continues to accrue an impressive list of partners as it ramps up production of farnesene, a versatile C15 hydrocarbon and the company’s first commercial product. Founded in 2003, Amyris originally set out to develop yeast that would produce a precursor to artemisinin, a potent anti-malaria drug whose production volumes were limited by a long process time. After that project was turned over royalty-free to sanofi-aventis for larger-scale development, Amyris shifted its attention to the other value compounds its...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa